- Home
- RSSS vs CTOR Comparison
RSSS vs CTOR Comparison
Compare RSSS & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- CTOR
- Stock Information
- Founded
- RSSS 2006
- CTOR 2021
- Country
- RSSS United States
- CTOR United States
- Employees
- RSSS N/A
- CTOR N/A
- Industry
- RSSS Business Services
- CTOR
- Sector
- RSSS Consumer Discretionary
- CTOR
- Exchange
- RSSS Nasdaq
- CTOR NYSE
- Market Cap
- RSSS 104.8M
- CTOR 89.9M
- IPO Year
- RSSS N/A
- CTOR N/A
- Fundamental
- Price
- RSSS $2.60
- CTOR $0.86
- Analyst Decision
- RSSS Strong Buy
- CTOR Strong Buy
- Analyst Count
- RSSS 1
- CTOR 2
- Target Price
- RSSS $6.00
- CTOR $4.50
- AVG Volume (30 Days)
- RSSS 62.0K
- CTOR 3.8M
- Earning Date
- RSSS 05-08-2025
- CTOR 05-21-2025
- Dividend Yield
- RSSS N/A
- CTOR N/A
- EPS Growth
- RSSS N/A
- CTOR N/A
- EPS
- RSSS N/A
- CTOR N/A
- Revenue
- RSSS $48,207,887.00
- CTOR N/A
- Revenue This Year
- RSSS $13.88
- CTOR N/A
- Revenue Next Year
- RSSS $7.30
- CTOR N/A
- P/E Ratio
- RSSS N/A
- CTOR N/A
- Revenue Growth
- RSSS 18.51
- CTOR N/A
- 52 Week Low
- RSSS $2.38
- CTOR $0.55
- 52 Week High
- RSSS $4.24
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- RSSS 26.00
- CTOR N/A
- Support Level
- RSSS $2.64
- CTOR N/A
- Resistance Level
- RSSS $3.05
- CTOR N/A
- Average True Range (ATR)
- RSSS 0.10
- CTOR 0.00
- MACD
- RSSS 0.00
- CTOR 0.00
- Stochastic Oscillator
- RSSS 8.09
- CTOR 0.00
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.